به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه "bnp" در نشریات گروه "پزشکی"

  • Sayyed Majid Sadrzadeh, Bahram Shahri, Mostafa Kamandi, Maryam Adimolmasali, Behrang Rezvani Kakhki, Hamideh Feiz Disfani *
    Introduction
    Recently, various serum markers have been used for the diagnosis and prognosis of acute heart diseases in emergency departments. Thus, the present study was designed and conducted to determine such a role.
    Methods
    This is an Analytical Cross-Sectional study conducted on the patients with syncope complaints. The patients were entered the study based on the inclusion and exclusion criteria and were subjected to initial evaluations including history, physical examination, ECG, blood sugar measurement, and, if necessary, brain CT scan, Doppler echocardiography, and CTA.
    Results
    A hundred people complaining of syncope were included in this study. The results showed that 19% and 81% of the subjects were suffering from cardiac and non-cardiac syncope, respectively. The average Pro BNP of the studied individuals was 196.06 ± 128.45 pg/ml. according to the results, age and length of hospitalization had a positive and significant relationship with the average Pro BNP (P value<0.01). Furthermore, the average Pro BNP was significantly higher in the people with positive TPI, cardiac syncope, and abnormalities in ECG and Doppler findings (P value<0.01). The results of the diagnostic value of Pro BNP in identifying cardiac syncope also showed that its sensitivity and specificity were 94.73% and 56.79%, respectively.
    Conclusion
    The results of this study showed that the increase in the Pro BNP values was associated with age, increased length of hospitalization, and ECG abnormalities. In addition, as an independent marker, Pro BNP had good acceptability in identifying cardiac syncope cases.
    Keywords: Syncope, Emergency Department, BNP, Prognosis
  • مهسا فخر غلامی، فاطمه صفری، علیرضا کریم الله*
    زمینه و هدف

    هایپرتروفی بطن چپ ناشی از فشار خون بالا فاکتور خطر مستقل نارسایی قلبی و مرگ ناگهانی است. پیشرفت هایپرتروفی عضله قلب با فعال شدن مسیرهای آپوپتوتیک در این سلول ها همراه است. تروپی سترون آنتاگونیست گیرنده 3-HT5 است که مطالعات اخیر اثرات محافظت قلبی آن را نشان داده اند. هرچند مکانیسم های مسیول این اثرات ناشناخته اند. هدف از این مطالعه، بررسی اثر تروپی سترون بر میزان نسخه برداری فاکتور ناتریورتیک BNP بعنوان مارکر هایپرتروفی و بیان ژن های پرو-آپوپتوتیک BAX و BAD در قلب هایپرتروف شده موش صحرایی است.

    روش ها: 

    24 سر موش صحرایی نر نژاد ویستار به گروه های زیر تقسیم شدند: 1- گروه کنترل شامل حیوانات دست نخورده 2- گروه هایپرتروفی بدون درمان 3- گروه هایپرتروفی دریافت کننده تروپی سترون با دوز روزانه 3 میلی گرم بر کیلوگرم به مدت 21 روز 4- گروه تروپی سترون که بدون مداخله جراحی صرفا دارو را به مدت 21 روز دریافت نمودند. مدل هایپرتروفی بطن چپ توسط جراحی و تنگی آیورت شکمی القا شد. بیان ژن های هدف توسط تکنیک  Real-time PCR اندازه گیری شد.

    یافته ها: 

    در گروه هایپرتروفی بدون درمان سطح BNP mRNA در مقایسه با گروه کنترل افزایش یافت (0/001 > p). در گروه تروپی‏سترون + هایپرتروفی سطح BNP mRNA در مقایسه با گروه بدون درمان بطور معنی داری کاهش یافت (0/05 > p) . سطح BAD mRNA در بافت عضله قلب گروه هایپرتروفی افزایش یافت  (0/001 > p). تیمار با تروپی سترون سطح BAD mRNA را نسبت به گروه هایپرتروفی به طور معنی داری کاهش داد (0/001 >  p). تغییرات بیان BAX در هیچ یک از گروه های آزمایش از نظر آماری معنی دار نبود.

    نتیجه گیری:

     تروپی سترون می تواند از پیشرفت هایپرتروفی القایی فشار خون بالا به نارسایی قلبی حداقل تا حدی با کاهش بیان BAD جلوگیری کند.

    کلید واژگان: آپوپتوز, تروپی سترون, هایپرتروفی بطن چپ, BAX, BAD, BNP
    Mahsa Fakhr Gholami, Fatemeh Safari, Alireza Karimollah*
    Background and Aim

    Hypertension-induced left ventricular hypertrophy is an independent risk factor of heart failure and sudden death. Progression of cardiac hypertrophy is accompanied by activation of apoptosis signaling pathways. Tropisteron is a 5HT-3 receptor antagonist that its cardioprotective effects has been revealed by recent studies. Though, the underlying mechanisms are still unclear. The aim of the current study is to investigate the effect of tropisetron on gene expression of BNP (as the hypertrophy marker) and pro-apoptotic factors (BAD and BAX) in the rat model of hypertrophic heart.

    Methods

    Male Wistar rats (n = 24) were divided to the following groups: (I) control group including intact animals, (II) un-treated hypertrophy group (hypertrophy), (III) tropisetron-treated rats (3 mg/kg/day, 21 days)  during progression of hypertrophy (tropisetron + hypertrophy group), (IV) tropisetron-treated rats without induction of hypertrophy (tropisetron group). The left ventricular hypertrophy model was induced by surgical abdominal aortic banding. Gene expression was assessed by Real-time PCR.

    Results

    cardiac BNP mRNA level increased significantly in Hypertrophy group compared to the control (p < 0.001). In the tropisetron + hypertrophy group, BNP mRNA level was decreased significantly when compared with un-treated Hypertrophy group (p < 0.05). The transcription level of BAD was also upregulated in left ventricle of un-treated hypertrophy group (p < 0.001 vs. control). However, in the Tropisetron+Hypertrophy group, BAD mRNA level was decreased significantly compared to the untreated hypertrophy group (p < 0.001). The transcription level of BAX did not change significantly among the experimental groups.

    Conclusion

    Tropisetron can prevent the progression of pressure overload-induced hypertrophy to heart failure at least in part by decreasing BAD expression.

    Keywords: Apoptosis, Tropisetron, Left ventricular hypertrophy, BAX, BAD, BNP​​​​​​​
  • Ruqaya M. Al Sultan *, Hazim A. Mohammed

    Thyroid hormones (THs) have different effects on the heart and peripheral vascular system. Several changes occur across different status of thyroid dysfunctions. Overt hyperthyroidism (OHyper) induces significant changes in cardiac functions. Untreated OHyper is a cause of heart failure (HF). B-type Natriuretic Peptide (BNP) synthesized primarily in the myocardium. Thus, it is recommended as a diagnostic and prognostic marker for patients with HF. The present study was conducted to measure the effects of OHyper on the BNP level. A case-control study was conducted at a private clinic; Mosul Daily Surgical Clinic, Mosul, Nineveh, Iraq. From 1st Oct., 2020 to 1st Mar., 2021. Thirty (30) apparently healthy subjects with normal thyroid functions; Euthyroid (EU) subjects regarded as control group. Another newly diagnosed thirty (30) OHyper patients were enrolled in this study after exclusion of any facts that affect BNP level as cardiac disease, hypertension, patient taking angiotensin converting enzyme inhibitor, and pregnant ladies. They were diagnosed on the basis of thyroid function tests (TFTs); Thyroid Stimulating Hormone (TSH), Free Triiodothyronine (FT3) and Free Thyroxine (FT4). Plasma level of BNP were measured in OHyper and EU subjects’ group. Plasma BNP level is higher in patients with OHyper than EU individuals with mean values of 27.40± 35.59 and 21.68± 28.57 pg ml-1, (p>0.05) respectively. Moreover, there was a positive correlation between plasma BNP and serum FT4 level in EU (r=0.31, p=0.01) and in OHyper patients (r=0.57, P=0.001). OHyper affect plasma BNP level possibly influencing the secretion of this peptide. Therefore, thyroid functions have to be considered when evaluating any high plasma BNP level.

    Keywords: Thyroid hormones (THs), Overt hyperthyroidism (OHyper), β- type natriuretic peptide, BNP, Heart Failure (HF)
  • Seyed Hossein Ojaghi Haghighi, Neda Hamed, Shiva Ebrahimi, Jafar Ghobadi, Hoorolnesa Ameli *
    Introduction

    Congestive heart failure is heart muscle failure that causes pulmonary congestion and eventually pulmonary edema, which despite recent medical advances, is still a progressive syndrome with high mortality, the prevalence of which has increased in recent decades. Therefore, in this study we compared lung ultrasound findings in acute heart failure patients with the BNP.

    Methods

    This study was performed in the emergency room of Imam Reza hospital in Tabriz. For patients entering the emergency room after taking a history, both standard gold (BNP) tests and beside ultrasound of the lung were performed. Ultrasound was performed at the same time as obtaining blood sample to ensure that the ultrasound specialist did not know the result of diagnosis. During the ultrasound, if there were multiple B-Lines that were at least 3 mm apart, patient was diagnosed with pulmonary edema due to heart failure.

    Results

    Number of participants in this study was 108 people, 54.6% of whom were men and the rest were women. The correlation coefficient between width and number of kerley lines was 0.79, between NT-pro BNP and width of kerley lines was 0.65 and between NT-pro BNP and number of kerley lines was 0.77, which indicates a significant positive correlation (P value <0.001).

    Conclusion

    The results of present study showed that in patients with acute heart failure, the number and width of kerley lines in pulmonary ultrasound evaluation increase rapidly. There is also a high correlation between number and length of kerley lines with NT-pro BNP serum values.

    Keywords: Congestive heart failure, BNP, ultrasound, bedside
  • سعیده سلیمی، شقایق پیروشعبانی، معصومه رجبی بذل، مینو یغمایی *
    سابقه و هدف
    پره اکلامپسی از عوارض شایع بارداری است. مطالعات قبلی نشان داده که سطح NT- pro BNP در بیماران پره اکلامپتیک بیش تر از زنان باردار با فشار خون طبیعی است. از آن جا که شدت پره اکلامپسی در شیوه اداره بیماران موثر است، هدف این مطالعه بررسی ارتباط سطح سرمی NT-pro BNP با شدت پره اکلامپسی بوده است.
    مواد و روش ها
    در این مطالعه توصیفی سطح NT-pro BNP در سه گروه زنان باردار نرمال، زنان باردار مبتلا به پره اکلامپسی غیر شدید و زنان باردار مبتلا به پره اکلامپسی شدید مورد بررسی قرار گرفت. معیارهای تشخیص و طبقه بندی پره اکلامپسی بر اساس راهنمای سال 2013 کالج متخصصان زنان و زایمان آمریکا بود. NT-pro BNP با روش الایزا اندازه گیری شد. برای تجزیه و تحلیل آماری از آزمون های آماری آزمون تی، فیشر، کروسکال والیس و من ویتنی استفاده گردید.
    یافته ها
    نتایج مطالعه روی 29 زن باردار نرمال، 30 زن باردار مبتلا به پره اکلامپسی غیر شدید و 31 زن باردار مبتلا به پره اکلامپسی شدید نشان داد که سطح NT-pro BNP در بارداران نرمال 26±40 پیکوگرم/ میلی لیتر، در افراد با پره اکلامپسی غیر شدید 33 ±55 پیکوگرم / میلی لیتر و در افراد با پره اکلامپسی شدید 37± 74 پیکوگرم/ میلی لیتر بود. این اختلاف سطح بین دو گروه با بارداری نرمال و افراد با پره اکلامپسی شدید تفاوت معنی دار داشت (0003/0=p).
    استنتاج: میزان NT-pro BNP در بارداران پره اکلامپتیک بیش تر از بارداران نرمال است و هم چنین با شدت پره اکلامپسی در ارتباط است. لذا شاید بتوان از آن به عنوان شاخصی جهت افتراق پره اکلامپسی شدید و غیر شدید استفاده کرد.
    کلید واژگان: حاملگی, پره اکلامپسی, N, terminal pro, BNP, شاخص شدت بیماری
    Saeedeh Salimi, Shaghayegh Peiro Shabani, Masoumeh Rajabibazl, Minoo Yaghmaei *
    Background and
    Purpose
    Preeclampsia is a serious condition in pregnancy. Previous studies have shown that NT-pro BNP level is higher in preeclamptic patients than that in pregnant women with normal blood pressure. Severity of preeclampsia is one of the critical factors in managing patients, so, this study aimed at investigating the relationship between the level of NT-pro BNP and severity of preeclampsia.
    Materials And Methods
    In this descriptive study, three groups of pregnant women with normal blood pressure (n= 29), non-severe preeclampsia (n= 30), and severe preeclampsia (n=31) were included. Diagnostic criteria and classification of preeclampsia were based on the guideline for hypertension in pregnancy by the American College of Obstetricians and Gynecologists, 2013. The level of NT-pro BNP was measured by ELISA. Data analysis was done applying t-test, fisher test, Kruskal Wallis, and Mann Whitney.
    Results
    The levels of NT-pro BNP were 40±26, 55±33, and 74±37 pg/ml in pregnant women with normal blood pressure, non-severe preeclampsia, and severe preeclampsia, respectively. Significant differences were found between the cases with normal blood pressure and those with severe preeclampsia in the level of NT-pro BNP (P= 0.003).
    Conclusion
    The level of NT-pro BNP in preeclamptic women was higher than that of the pregnant women with normal blood pressure which was correlated with the severity of preeclampsia too. It seems that the level of NT-pro BNP could be used to differentiate severe preeclampsia from non-severe cases.
    Keywords: pregnancy, preeclampsia, N, terminal pro, BNP, severity of illness index
  • Hassan Moladoust, Arsalan Salari, Seyed Hassan Voshtani *
    BackgroundCongenital heart disease (CHD) is the most common cause of major congenital birth defect. The aim of this study was to investigate the association of CHD with serum levels of Tumor necrosis factor-α (TNFα), Interleukin 6 (IL-6), and B-type Natriuretic Peptide (BNP) in infant and children.
    Materials and MethodsThe present study was conducted in Heshmat heart hospital and 17 Shahrivar hospital Rasht city, Iran. In 50 children, 25 with CHD and 25 age and sex-matched healthy children (were selected from companions or patients without heart disease), 3 ml vein blood samples of right hand were taken by a trained nurse and samples were sent to a private laboratory. After separation, the plasma placed at temperature of -20 °c. ELISA kits used for measuring BNP and eBioscience Bender MedSystems GmbH kit for measuring IL-6 and TNF-α. The results were entered into SPSS software (version 20.0).
    ResultsSerum levels of TNF-α and IL-6 and BNP in the healthy and patient groups were evaluated and by comparing results of the two groups there was no significant difference in serum levels of TNF-α and IL-6, but the serum levels of BNP has significant difference between two groups (80.7 ± 52.5 pg/ml vs. 455.4 ± 550.4 pg/ml, P=0.003). There was no significant relationship between BNP changes with changes in serum TNF-α, IL-6 levels.
    ConclusionOur study provided conclusive evidence BNP level is elevated in children with CHD; and significant relationship was observed between incidents of CHD respect to changes in serum BNP level.
    Keywords: BNP, Children, Congenital Heart Disease, Interleukin 6, TNF-?
  • Mehran Ghahramani *, Sara Karbalaeifar
    Introduction
    Myocardial infarction (MI) is the irreversible cell death caused by ischemia in parts of myocardium. Atrial and brain natriuretic peptides (ANP and BNP) are known as strong markers of myocardial infarction. This research aimed to evaluate the effect of precedent of six-week light intensity interval training (LIIT) on the ANP and BNP gene expression in rats after Myocardial Infarction.
    Method
    Twelve Wistar male rats of 10 weeks old and mean weight 250-300gr were allocated in two groups with six Rats in each groups of 1. LIIT (60 minutes interval running on a treadmill, each cycle including four minutes of running with an intensity of 55-60% VO2max and two minutes of active recovery with a 45-50% VO2max intensity, three days a week for six weeks) and 2. control group (without any precedent of training). Real-time PCR was used to assess the expression of ANP and BNP genes in myocardium (after inducing MI By blocking left coronary artery by surgery). For statistical analysis of data independent sample t test (p≤0.05) was used.
    Results
    Light intensity interval training has significant effect on decreasing the gene expression of ANP (p=0.01) and BNP (p=0.001) in rats after myocardial infarction.
    Conclusion
    It appears that adaptation to light intensity interval training controls and moderates the secretion of cardiac hormones in rats after myocardial infarction.
    Keywords: Myocardial Infarction, ANP, BNP, Light Intensity Interval Training
  • محسن داودی، مقصود پیری*، محمدعلی آذربایجانی، حسن متین همایی
    زمینه و هدف
    وضعیت پپتیدهای ناتریورتیک می تواند پیش بینی کننده بیماری قلبی- عروقی در افراد مسن باشد. هدف از این مطالعه، بررسی اثر 12 هفته تمرین هوازی در آب بر تغییرات پپتیدهای ناتریورتیک مغزی (Brain Natriuretic Peptide: BNP) و دهلیزی (Atrial Natriuretic Peptide: ANP) مردان با بیماری قلبی- عروقی بود.
    روش تحقیق: تعداد 40 نفر از بیماران قلبی- عروق کرونری شهر شیراز با دامنه سنی 65-50 سال به روش داوطلبانه و هدفمند انتخاب شدند. آزمودنی ها به طور تصادفی به چهار گروه 10 نفره شامل: 1) تمرین 2) تمرین و مصرف آتورواستاتین 3) آتورواستاتین 4) کنترل تقسیم شدند. سپس در دو مرحله پیش آزمون و پس آزمون، خون گیری انجام شد. گروه های 1و 2 به مدت 12 هفته برنامه تمرین منتخب هوازی در آب را انجام دادند، گروه آتورواستاتین، 20 میلی گرم به صورت روزانه دارو را طبق تجویز پزشک مصرف کردند. تمرین شامل 12 هفته و هر هفته 3 جلسه براساس طراحی تمرین منتخب هوازی در آب با شدت ثابت 60-55 درصد ضربان قلب هدف فعالیت کردند. هر هفته، سه و نیم دقیقه براساس اصل اضافه بار فزآینده تمرین اضافه شد. از آزمون T وابسته برای بررسی اختلاف پیش آزمون و پس آزمون، تفاوت بین گروهی از طریق تحلیل واریانس یک راهه ANOVA با پس آزمون Tukey استفاده شد (05/0P≤).
    یافته ها
    میانگین BNP چهار گروه آزمودنی ها در پس آزمون گروه های تمرین (001/0P=)، آتورواستاتین (002/0P=) و تمرین -آتورواستاتین (000/0P=) و میانگین ANP چهار گروه آزمودنی ها در پس آزمون گروه های تمرین (002/0P=)، آتورواستاتین (001/0P=) و تمرین- آتورواستاتین (000/0P=) که حداقل تغییرات در BNP به میزان 18/13 درصد و ANP به میزان 58/9 درصد مشاهده شد.
    نتیجه گیری
    انجام تمرینات هوازی توام با مصرف روزانه آتورواستاتین می تواند تاثیر قابل ملاحظه ای بر کاهش پپتیدهای ناتریورتیک بیماران قلبی عروقی داشته باشد.
    کلید واژگان: آتورواستاتین, بیماران قلبی, عروقی, تمرین هوازی در آب, پپتیدهای ناتریورتیک مغزی (BNP) و دهلیزی (ANP)
    Mohsen Davoodi, Maghsoud Peeri *, Mohammad Ali Azarbayjani, Hassan Matin Homaee
    Background And Aim
    The present study aimed at investigating the effect of a 12-week aerobic water exercise and atorvastatin on of Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) changes in older men with cardiovascular diseases.
    Materials And Methods
    In the current study, 40 patients with cardiovascular disease, aged 50-65yrs, who were volunteers for the research were divided in to four equal groups including1.exercise, 2.exercise plus atorvastatin, 3.atorvastatin, and 4.control. Then, blood was taken before and after the interventions. Groups 1 and 2 performed the specific water aerobic exercise 3 times a week for 12 weeks. Group 3 took 20mg of atorvastatin daily under a physician Water aerobic exercise lasted 12 weeks, 3 periods a week, with intensity of 55-60% of heart-beat. Every week, due to overtax principle, 3.5 minutes was added to exercise period. In order to determine the difference between pre-test and post-test, dependent T was applied. Intergroup difference was determined through ANOVA using Tukey for post-test; (P≤0.05).
    Results
    ANOVA application revealed that mean of functional variables in pre-test compared to that of post-test was significantly different. Mean post-test of BNP in the four groups exercise, atorvastatin, exercise plus atorvastatin and control was P= 0.001, P=0.002, P=0.000, respectively. But mean post-test of ANP in the above mentioned groups was P=0.022, P=0.001, P=0.000, respectively.
    Conclusion
    Aerobic exercises together with daily taking of atorvastatin can have significant effects on decreasing natriuretic peptides and CVDs.
    Keywords: ANP, BNP, Atorvastatin, Cardiovascular Disease
  • Noor Mohammad Noori, Alireza Teimouri*, Iraj Shahramian, Samaneh Akhavan Sales
    Objective
    This study aimed to assess Brain Natriuretic Peptide in early diagnose of cardiac function in children with Congenital Heart Diseases.
    Methodology
    This study was performed on children with CHD and healthy. Severity of heart failure modified Ross classification system was used for grouping patients in four classes. For all participants, height, weight and head circumference were measured. From participants 3 cc blood samples was taken and after separation, the plasma placed at temperature of -80 c. After collecting all samples they were in testing using an ELISA BNP kit. For 50 children in control group statistical methods used to generate RV and PA pressure randomly. The data were analyzed using SPSS for Windows, Version, 15.0 (Chicago,SPSS Inc. USA) with 0.05 for the level of significant.
    Results
    BNP, RV pressure, PA pressure, HB and O2 saturation had different means in cyanotic, Acyanotic and and control significantly. BNP, RV, PA , HB and O2Sat had different means in case and control significantly. , RV, HB and O2 saturation had different means significantly acordance with the sevirity of disease.BNP had correlation with PA and PA had correlation with Qp/Qs ratio ,Rp/Rs ratio , RV and O2Sat significantly .
    Conclusion
    At the end from the results of the study concluded that BNP levels in children with chd increased.
    in patients with pulmonary hypertension , with increasing the level of pulmonary hypertension the BNP will increase. BNP increasing had high association with the severity of heart failure.
    Keywords: BNP, Diagnostic, CHD, Children
  • Noor Mohammad Noori, Sima Savadkoohi, Alireza Teimouri*, Fatemeh Alizadeh
    Background
    Acute respiratory distress (ARD) is a critical respiratory failure due to lung injury of neonates leading to the clinical appearance of poor lung compliance. The aimed of the study was to evaluate the diagnostic values in differentiating respiratory from heart diseases with using of N-terminal pro brain natriuretic peptide (NT-pro BNP) and Atrial natriuretic peptide(ANP) in neonates.
    Material and
    Methods
    Ninety neonates randomly collected from those who hospitalized in the neonate ward of the Ali Ebne abitalib Hospital, Zahedan, Iran .After taking blood samples ANP and NT pro Brian Natriuretic peptide using ELISA kit were measured. The separated serum was kept in -20 °C until BNP measurement. 250 μl of the patients’ serum was isolated to assess pro BNP level using ELISA kit (USA). Data were analyzed using SPSS- 20 with considering of P
    Results
    NT pro-BNP level had the highest in cardiac patients and followed by respiratory. The level of NT pro-BNP for control neonates had the lowest. These levels had significant variation (P
    Conclusion
    Many studies revealed that NT pro-BNP cannot be used as a tool for differentiation between cardiac and respiratory as a cause of respiratory distress during neonate, but the results of the present study showed that it would be good biomarker.
    Keywords: Atrial natriuretic peptide, Neonates, NT pro, BNP, Respiratory diseases
  • Noor Mohammad Noori, Mehdi Mohammadi, Hossein Ali Khazaei, Maziar Mahjoubifard
    Background
    Heart disease is one of the leading causes of disability in major thalassemia patients. Timely diagnosis and effective treatment in these patients are essential. The aim of this study is to evaluate the diagnostic value of BNP in the diagnosis of heart involvement compared with echocardiographic findings in patients with major thalassemia.
    Methods
    This case-control study was carried out in patients with major thalassemia aged 9-25 years old admitted to Aliasghar hospital from October 2010 to November 2011. Patients with no obvious cardiac abnormalities were included. 80 major thalassemia patients with 80 healthy children matched by age and sex were entered and for both, echocardiography was performed by a pediatric cardiologist. The serum level of Brain Natriuretic Peptides (BNP) was also evaluated. The data were analyzed by SPSS17.
    Results
    The groups studied were matched well regarding age and gender (P =0.1346, 0.429). Regarding the echocardiographic results, some of the parameters of the left heart in case group were significantly higher than control group as well as some of the parameters of right heart. The mean value of BNP in case group was higher significantly. There was a significant correlation between BNP and right heart MPI (r = 0.229, P = 0.041) and age (r = 0.237, P = 0.035).
    Conclusion
    Based on the results, systolic and diastolic function in patients with major beta thalassemia were impaired. Therefore, measurement of BNP level in addition to serial echocardiography is recommended to early diagnose heart involvement in patients with major beta thalassemia without clinical symptoms.
    Keywords: major thalassemia, echocardiography, BNP, children
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال